Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9762
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFoo, Serene Sen
dc.contributor.authorRamdave, Shankaren
dc.contributor.authorBerlangieri, Salvatore Uen
dc.contributor.authorScott, Andrew Men
dc.date.accessioned2015-05-15T22:58:26Z
dc.date.available2015-05-15T22:58:26Z
dc.date.issued2004-06-01en
dc.identifier.citationAustralasian Radiology; 48(2): 214-6en
dc.identifier.govdoc15230758en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9762en
dc.description.abstractAccurate staging of cancer has a critical role in optimal patient management. Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) is superior to CT in the detection of local and distant metastases in patients with non-small cell lung cancer. Although Tc-99 m methylene diphosphonate (MDP) bone scanning is well established in the evaluation of bone metastases, there are conflicting reports on the use of FDG PET in the evaluation of skeletal metastases. We report on a patient with locally advanced lung carcinoma in whom FDG PET accurately identified previously unsuspected widespread asymptomatic bone metastases (bone scan and X-rays negative, confirmed on MRI). Assessment of glucose metabolism with FDG PET might represent a more powerful tool to detect bone metastases in lung cancer compared with conventional bone scans.en
dc.language.isoenen
dc.subject.otherBone Neoplasms.radionuclide imaging.secondaryen
dc.subject.otherFatal Outcomeen
dc.subject.otherFluorodeoxyglucose F18.diagnostic useen
dc.subject.otherHumansen
dc.subject.otherLung Neoplasms.pathologyen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherRadiopharmaceuticals.diagnostic useen
dc.subject.otherTechnetium Tc 99m Medronate.diagnostic useen
dc.subject.otherTomography, Emission-Computeden
dc.titleDetection of occult bone metastases of lung cancer with fluorine-18 fluorodeoxyglucose positron emission tomography.en
dc.typeJournal Articleen
dc.identifier.journaltitleAustralasian radiologyen
dc.identifier.affiliationDepartment of Nuclear Medicine and Centre for PET, Austin Hospital, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1111/j.1440-1673.2004.01300.xen
dc.description.pages214-6en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/15230758en
dc.type.austinJournal Articleen
local.name.researcherBerlangieri, Salvatore U
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.